Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.71 USD
-0.17%
Market Closed
Updated:
Apr 25, 2024
Abbott Laboratories
Other Current Assets
|
Abbott Laboratories
Other Current Assets Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Assets
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-6%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Current Assets
$1.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Assets
$937m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Current Assets
$386.1m
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Current Assets
$857m
|
CAGR 3-Years
21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-5%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Assets
$176.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
7%
|
See Also
What is Abbott Laboratories's Other Current Assets?
Other Current Assets
2.3B
USD
2.3B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Other Current Assets amounts to 2.3B USD.
What is Abbott Laboratories's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-6%
-6%
Over the last year, the Other Current Assets growth was 5%. The average annual Other Current Assets growth rates for Abbott Laboratories have been 5% over the past three years , 6% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
